Skip to content
Screener

Ginkgo Bioworks DNA Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$5.67M+15.8%
eXoZymes, Inc. logo
eXoZymes, Inc.EXOZ
$289.8K+22.4%
TEC
Bio-TechneTECH
$14.18M+0.9%
Sana Biotechnology logo
Sana BiotechnologySANA
$14.88M+14.4%
Emergent Biosolutions logo
Emergent BiosolutionsEBS
$1.5M-16.7%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$36.2M-12.3%

Other financials

Income statement

See full
Revenue$20.2M-48.5%
Gross profit$18.4M-45.4%
Operating income-$58.5M-0.7%
Net income-$46.7M+22.5%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$172.0M-31.6%
Total debt$404.1M-5.8%
Total equity$420.3M-31.4%
Total assets$990.0M-19.6%

Cash flow

See full
Operating cash flow-$44.3M-10.0%
CapEx$2.6M+6,792%
Free cash flow-$46.9M-16.4%

Valuation

See full
Market cap$520.64M-26.0%
Enterprise value$752.73M-14.6%
P/S4.7×+1.3×

Profitability

See full
Gross margin91.8%
Operating margin-259.9%+1,304pp
Net margin-260%+718pp
FCF margin-156.3%+38.7pp

Returns & leverage

See full
Return on equity-56.3%+23.1pp
Debt / equity+0.3×
Current ratio4.6×-0.8×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The source filing: Ginkgo Bioworks’s 10-K, filed February 26, 2026.

Filed
Feb 26, 2026, 4:34 PM EST
Fiscal year
FY2025
Accession
0001628280-26-012346
Years Ending December 31,Operating LeasesFinance Leases
202960,271
203059,301
Thereafter371,682
Total undiscounted payments662,79920
Less: imputed interest(222,934)
Total lease liability439,86520
Less: current portion of lease liability(22,787)(20)
Lease liabilities, non-current$417,078

Item 16. Form 10-K Summary

FAQ

What is Ginkgo Bioworks's operating lease liabilities (current)?
Ginkgo Bioworks (DNA) reported operating lease liabilities (current) of $22.79M in Q4 2025.
How has Ginkgo Bioworks's operating lease liabilities (current) changed year-over-year?
Ginkgo Bioworks's operating lease liabilities (current) decreased by 20.4% year-over-year, from $28.63M to $22.79M.
What is the long-term trend for Ginkgo Bioworks's operating lease liabilities (current)?
Over 4 years (2021 to 2025), Ginkgo Bioworks's operating lease liabilities (current) has grown at a -39.2% compound annual growth rate (CAGR), from $166.7M to $22.79M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Ask your AI about Ginkgo Bioworks's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude